Nathan R. Mason, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10717 W State St, Star, ID 83669 Phone: 208-302-6300 Fax: 208-302-6355 |
Derek Kohlhase, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 10717 W State St, Star, ID 83669 Phone: 208-302-6300 Fax: 208-302-6355 |
Dr. Thomas Richard Young Iii, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4815 N High Country Way, Star, ID 83669 Phone: 208-761-6884 |
Katherine Lea Mcdonough, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 10717 W State Street, Star, ID 83669 Phone: 208-302-6300 Fax: 208-302-6355 |
News Archive
In a study to be presented on Feb. 7 at 1:30 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report findings which suggest remifentanil patient controlled analgesia is not equivalent to epidural analgesia for pain, pain appreciation scores, and overall satisfaction in women who request for pain relief during labor.
Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced its first European symposium, detailing the use of Translational Platforms including Patient-Derived Xenograft (PDX) models in oncology drug discovery and development. The conference will be held on Wednesday 11th February, at the headquarters of One Nucleus in Cambridge, UK and will welcome experts from renowned pharmaceutical companies and prominent academics working in oncology.
NorayBio, a bioinformatics company located at the Bizkaia Technological Park (Basque Country) and specialising in developing software for the biosciences, has launched a new software for cancer research on to the market - BITIA, primarily aimed at research centres and cancer wards in hospitals.
UC San Diego Sulpizio Family Cardiovascular Center has received Modern Healthcare's highest design honor, the 2012 Modern Healthcare Design Award. Out of more than one hundred entries, only one other project received this honor in 2012.
In an effort to combat a growing worldwide epidemic of Nonalcoholic Fatty Liver Disease (NAFLD), scientists have discovered a new target and a new therapy that has shown promising results in preclinical mouse models, according to researchers at the University of Colorado Anschutz Medical Campus.
› Verified 3 days ago